North America Immunodiagnostic Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Immunodiagnostic Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Immunodiagnostic Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Immunodiagnostic Market Regional Analysis

6.2 North America Immunodiagnostic Market Revenue 2019-2028 (US$ Million)

6.3 North America Immunodiagnostic Market Forecast Analysis

7. North America Immunodiagnostic Market Analysis – by Product

7.1 Enzyme-Linked Immunosorbent Assays

7.1.1 Overview
7.1.2 Enzyme-Linked Immunosorbent Assays: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Chemiluminescence Immunoassays

7.2.1 Overview
7.2.2 Chemiluminescence Immunoassays: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Radioimmunoassays

7.3.1 Overview
7.3.2 Radioimmunoassays: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Immunodiagnostic Market Analysis – by Clinical Indication

8.1 Infectious Diseases

8.1.1 Overview
8.1.2 Infectious Diseases: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Hepatitis+HIV

8.2.1 Overview
8.2.2 Hepatitis+HIV: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Gastrointestinal

8.3.1 Overview
8.3.2 Gastrointestinal: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Metabolics

8.4.1 Overview
8.4.2 Metabolics: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Endocrinology

8.5.1 Overview
8.5.2 Endocrinology: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Immunodiagnostic Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Clinics

9.2.1 Overview
9.2.2 Clinics: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Diagnostic Laboratories

9.3.1 Overview
9.3.2 Diagnostic Laboratories: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Academic & Research Institutes

9.4.1 Overview
9.4.2 Academic & Research Institutes: North America Immunodiagnostic Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Immunodiagnostic Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Immunodiagnostic Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Immunodiagnostic Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Immunodiagnostic Market Breakdown, by Product
10.2.1.1.2 US: North America Immunodiagnostic Market Breakdown, by Clinical Indication
10.2.1.1.3 US: North America Immunodiagnostic Market Breakdown, by End User

10.2.1.2 Canada: North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Immunodiagnostic Market Breakdown, by Product
10.2.1.2.2 Canada: North America Immunodiagnostic Market Breakdown, by Clinical Indication
10.2.1.2.3 Canada: North America Immunodiagnostic Market Breakdown, by End User

10.2.1.3 Mexico : North America Immunodiagnostic Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Immunodiagnostic Market Breakdown, by Product
10.2.1.3.2 Mexico : North America Immunodiagnostic Market Breakdown, by Clinical Indication
10.2.1.3.3 Mexico : North America Immunodiagnostic Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 F. Hoffmann-La Roche Ltd

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 DiaSorin S.p.A.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Danaher Corp

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Thermo Fisher Scientific Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Siemens Healthineers AG

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 PerkinElmer Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 bioMerieux SA

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Immunodiagnostic Market